4.50 - Ivosidenib & Aza vs Aza, the AGILE, 6 huge problems; Journal club
Apr 21, 2022•20 min
Episode description
I perform an analysis of the AGILE trial that came out in NEJM today; I find 6 huge problems. Follow PS on twitter; and write to us to let us know what you think
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast